Track 1: Neuro-Oncology
Neurooncology has defined the study of brain and spinal cord neoplasms, many of which are (at least eventually) very dangerous and life-threatening (astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumors are among the many examples of these). Among the malignant brain cancers, brainstem glioma and pons, glioblastoma multiforme, and high-grade (highly anaplastic) astrocytoma are among the worst.
Neuro Oncology Conference | Neuro Oncology Management | Neuro Oncology Global Meetings | Neuro Oncology 2021 | Neuro Oncology Safety conference | Neuro Oncology Events
Track 2: Brain Tumour
A Brain tumor occurs when abnormal cells form within the brain. There are two main types of tumors: cancerous (malignant) tumors and benign (non-cancerous) tumors. A malignant tumor can be divided into a primary tumor, which starts within the brain, and a secondary tumor, which has spread from elsewhere, known as a brain metastasis tumor. All types of brain tumors may produce some symptoms that vary depending on the part of the brain involved. These symptoms may include headaches, seizures, muscle weakness, problems with vision, vomiting, and mental changes.
Neuro Oncology Conference | Neuro Oncology Management | Neuro Oncology Global Meetings | Neuro Oncology 2021 | Neuro Oncology Safety conference | Neuro Oncology Events
Track 3: Metastatic Cancer
Metastatic Cancer can spread from where it is obtained to another part of the body (such as the breast or lungs). A metastatic tumor is considered cancer and is malignant. Cancer in another part of the body is called metastatic or secondary cancer. For example, when colon cancer spreads to the liver, the cancer cells in the liver are colon cancer cells. It is metastatic colon cancer, not liver cancer.
Neuro Oncology Conference | Neuro Oncology Management | Neuro Oncology Global Meetings | Neuro Oncology 2021 | Neuro Oncology Safety conference | Neuro Oncology Events
Track 4: Meningioma
Meningioma is referred as to a slow-growing Brain tumor, but its origin is not from the brain tissue. Meningitis is often a benign tumor arising from Arachnoidal cells of the Meninges of the brain and spinal cord. Meningiomas usually grow inward slowly, causing pressure on the Brain or Spinal cord. They interfere with the normal functions of the Brain after reaching a large size. They represent about one-third of all Primary Brain Tumour and occur most frequently in middle-aged females.
Neuro Oncology Conference | Neuro Oncology Management | Neuro Oncology Global Meetings | Neuro Oncology 2021 | Neuro Oncology Safety conference | Neuro Oncology Events
Track 5: Paediatric Neuro oncology
Paediatric Neuro oncology is the term used to encompass all malignant conditions among children with cancer, including blood conditions such as leukemia, paediatric oncologists and pediatric hematologists, work within a national framework of cancer to ensure they provide the most effective care. The major range of cancers in children includes leukemia, lymphomas brain tumors. Most of the cancers affecting children differ from those affecting adults.
Neuro Oncology Conference | Neuro Oncology Management | Neuro Oncology Global Meetings | Neuro Oncology 2021 | Neuro Oncology Safety conference | Neuro Oncology Events
Track 6: Gangliocytomas
Gangliocytoma is a rare indolent Central Nervous system tumor that is made up of mature neurons arising anywhere within the Neuroaxis. They differ from gangliogliomas as they lack neoplastic glial cells. Treatment involves surgical removal of the tumor. These are Neuroepithelial Tumour which line the ventricles of the brain and produce Cerebrospinal fluid.
Neuro Oncology Conference | Neuro Oncology Management | Neuro Oncology Global Meetings | Neuro Oncology 2021 | Neuro Oncology Safety conference | Neuro Oncology Events
Track 7: Angiogenesis in neuro Oncology
Angiogenesis theatrically a critical role in the maturation and spread of cancer, it also plays a major role in the transition of tumor cells from a benign state to a malignant (cancerous), leading to the use of angiogenesis evasion in the treatment of cancer.
Neuro Oncology Conference | Neuro Oncology Management | Neuro Oncology Global Meetings | Neuro Oncology 2021 | Neuro Oncology Safety conference | Neuro Oncology Events
Track 8: Novel Therapies in Neuro-Oncology
The Response Assessment of Neuro-Oncology (RANO) Working Group is an international, multidisciplinary effort to develop new standardized response Clinical trials in Brain tumors. The Surgery Working Group of Neuro oncology identified surgically related End-point evaluation problems that were not addressed in the original MacDonald criteria. This led to the initiation of an International effort in Neuro Oncology to develop Novel Response and Progression Assessment Criteria.
Neuro Oncology Conference | Neuro Oncology Management | Neuro Oncology Global Meetings | Neuro Oncology 2021 | Neuro Oncology Safety conference | Neuro Oncology Events
Track 9: Advancements in Neuro-Oncology
In low-grade Gliomas, stereotactically guided conformal Radiotherapy should lead to a significant reduction of Radiation-associated late toxicity, while it selected groups of high-grade Gliomas the use of adjuvant or Neo-adjuvant Chemotherapy may improve survival. In primitive Neuroectodermal Tumour Prognostic Biological markers have been identified that are undergoing prospective evaluation.
Neuro Oncology Conference | Neuro Oncology Management | Neuro Oncology Global Meetings | Neuro Oncology 2021 | Neuro Oncology Safety conference | Neuro Oncology Events
Track 10: Radiation Oncology
Radiation Oncology encompasses all facets, of research that whack, on the treatment of cancer using radiation. It discloses verdict in molecular and cellular radiation oncology, radiation technology, radiation physics, and clinical oncology.
Neuro Oncology Conference | Neuro Oncology Management | Neuro Oncology Global Meetings | Neuro Oncology 2021 | Neuro Oncology Safety conference | Neuro Oncology Events
Market Analysis:
Oncology Market size was valued at $136.7 billion in 2019 and is poised to grow at a CAGR of 11.9% during the forecast period 2020-2025. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
Cancer is a disease, which involves the abnormal growth of cells that result in the formation of a tumor. However, a benign tumor is not cancer. The abnormal tumor cells tend to spread to other local tissues and different parts of the body through the blood and lymphatic system. Treatment of cancer depends upon the stages of the disease progression.
Increased prevalence of cancer, unhealthy lifestyle and increasing geriatric population are the primary factors driving the growth of the oncology market. High market growth potential in developing nations, rise in the number of pipeline products, and the upsurge in demand for personalized medicines are poised to create new opportunities for the market players during the forecast period 2020-2025.
Target audience
Why to attend?
International Conference on Neurooncology tends to bring together worldwide distinguished academics in the field of Neuro-oncologist, Oncologist, Radiation Oncologist, Medical Oncologists, pharmacologists, Brain cancer specialists, Paediatric Neuro Oncologists, Neuroscience Brain researchers, Public Health professionals, Scientists, Academicians, Industry researchers, Scholars to exchange about state of the art Research and Technologies and to bring discoveries of cancer to Patients. Attending an International conference is for Professional Development and to understand the current state of research and the challenges to future discovery.
The Conference aims to provide a platform to academicians and practitioners from multiple disciplines to debate and deliberate on social change that is encompassed by innovation and technology.
For more details please visit: https://www.meetingsint.com/conferences/neurooncology
Who should sponsor/exhibit:
Hospitals, Health care
Educational Institutes
Cancer research Centres
Associations
Societies
Industries
Communities
Cancer pharma industries.
Charitable Foundations focused on funding research, advocating for and supporting the needs
Benefits of attending:
Networking Opportunities, Grow Your Professional Network
Build Your Knowledge Base
Expand Your Resources
Meet Experts & Influencers Face to Face
Learning in a New Space
Break Out of Your Comfort Zone
New Tips & Tactics
Greater Focus
Top Industries Representation
Abstracts will be published in the conference souvenir and respective international journals
Each Abstract will receive a unique (DOI) Number provided by CrossRef
Website visibility to more than 35K visitors in less than 6 months
Laudable talks by the top-notch of the Global Scientific Community
The Serendipity of the Random Workshop
Will be felicitated with International Organizing Committee Member (IOCM)
Remarkable Awards and Global Recognition to meritorious Researchers
Related Societies:
The Society for Neuro-Oncology
The Indian Society Of Neuro-Oncology
World Federation of Neuro-Oncology Societies (WFNOS)
Society for Neuro-Oncology Annual Meeting | Conference
Pakistan Society of Neuro-Oncology
Japan Society for Neuro-Oncology
International society of pediatric oncology
British Neuropath logical Society
British Neuroscience Association
British Society of Neuroradiologists
European Association of Neuro-Oncology (EANO)
European Association for Cancer Research
Top Universities Worldwide:
USA: Columbia University
University of California Los Angeles, USA
University of California San Diego,USA
University of California San Francisco,USA
Yale University, USA
Duke University,USA
Baylor University,USA
China : The Hong Kong University of Science and Technology
China Seoul National University,China
The Chinese University of Hong Kong,China
China National Taiwan University,China
Taiwan Tsinghua University,China
Osaka University,China
Japan Fudan University,,China
China Mahidol University ,China
Funding Bodies in Global Health: Council for Scientific and Industrial Research Japan
Conclusion:
Neurooncology 2021 will bring together experts like Neuro oncologist, Clinicians, a Brain cancer specialist, Neuropathologist, Business delegates, Medical practitioners, Care specialists, academic professionals, and students from all over the world to share an interest in the genetic pathways underlying neurooncology techniques to identify those genetic pathways, and the use of genetics and genomics as tools to develop therapeutics. The change in the act of neurooncology from an indicative to a diagnostic to a therapeutic specialty has empowered neurologists to settle on progressively critical choices and suggestions for patients. The new activity has recognized the need for an examination that could, inside the following 10 years, significantly enhance the lives of individuals in danger of or living with neurological scatters.
Meetings Int. is a worldwide pioneer in delivering top notch gatherings, workshops and symposia in every significant field of science, innovation and medication worldwide receives 400,000+ online visitors with 1000+ sessions which confirm the outstanding pool of new users and visitors creating a platform to build your market place globally. Since its initiation, Meetings Int. has been related with national and global affiliations, organizations and elevated level people, committed to have world class meetings and occasions so its provide a big platform to show your product and advertise. The explorer’s traffic is the benchmark for advertisement and the Neurooncology Conference website is continually dragged in observer over the world. As specify by the Google Analytics, in excess of 12,836 researchers and industrials are visiting to our conference sites Neurooncology 2021 virtual seminar help you to put the spotlight on your brand by advertising with more than 9 million+ readers worldwide and about 5 million+ hits every month on our site. We provide a good opportunity to boost your business on our platform. We offer a range of eye-catching advertising spaces and branding. Researchers from significant nations including United States, Japan, United Kingdom, India, France, Taiwan, and Germany etc. Visit our conference site. Subscribers and conference attendees can be your upcoming enthusiastic customers. We maintain high quality and ethical standards in event industry, which makes us unique and better than the rest. Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.
For further queries, connect our Program Manager at: neuro@theexpertsmeet.com
you can also connect us via WhatsApp: +65-3158-1626
We are announcing Young Scientist Awards through International Conference on Neurooncology which is scheduled in Singapore city, Singapore during July 28-29, 2021. This Neurooncology 2021 focuses to “New Challenges and latest Development in Neurooncology.
Neurooncology 2021 and upcoming conferences will recognise participants who have significantly added value to the scientific community of Medical science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.
Neurooncology 2021 focuses mainly on Neurooncology, Brain tumour, Metastatic Cancer, Meningioma, Paediatric Neuro oncology, Gangliocytoma, Angiogenesis in Neuro Oncology.
Neurooncology 2021 operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.
Eligibility:
Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates Persons from Scientific Industry can also participate.
Benefits:
The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.
Acknowledgement as YRF Awardee
Promotion on the conference website, Young Scientist Awards and certificates
Link on the conference website
Recognition on Meetings Int. Award Page
Chances to coordinate with partners around the world
Research work can be published in the relevant journal without any publication fee
Criteria:
All presented abstracts will automatically be considered for the Award.
All the presentation will be evaluated in the conference venue
All the awards will be selected by the judges of the award category
The winners of the Young Scientist Award will receive award certificate.
The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.
Guidelines:
All submissions must be in English.
The topic must fit into scientific sessions of the conference
Each individual participant is allowed to submit maximum 2 papers
Abstract must be submitted online as per the given abstract template
Abstracts must be written in Times New Roman and font size will be 12
Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference
Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for
publication at the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of award.
Award Announcements:
Official announcement of the recipients will occur after the completion of Neurooncology 2021.
Postdoctoral researcher at UC Riverside
India